Skip to main content

Table 2 Biochemical parameters of HCC and HCV cases

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

Biochemical parametersHCC patientsControlp value
ALT (IU)55.8 ± 49.450.4 ± 27.70.660
AST (IU)106.4 ± 93.050.9 ± 26.3< 0.001*
T. bilirubin (mg/dL)4.5 ± 4.90.72 ± 0.4< 0.001*
HB (g/dL)9.7 ± 1.713.8 ± 1.4< 0.001*
WBC (×103)9.2 ± 5.46.5 ± 1.70.009*
Platelets (×103)134.3 ± 99.5242.5 ± 65.4< 0.001*
PT (seconds)23.0 ± 5.712.6 ± 0.8< 0.001*
Albumin (g/dL)2.2 ± 0.44.0 ± 0.6< 0.001*
AFP (ng/mL)1978.9 ± 3866.62.6 ± 2.7< 0.001*
  1. HCC hepatocellular carcinoma, HCV hepatitis C virus, ALT alanine transaminase, AST aspartate transaminase, HB hemoglobin, WBC white blood cell, PT prothrombin time, AFT alphafetoprotein
  2. aMann-Whitney test
  3. *Statistically significant at p < 0.05